Zobrazeno 1 - 10
of 51
pro vyhledávání: '"Vasudevan Nampoothiri R"'
Autor:
Saj F; Department of Clinical Hematology and Medical Oncology, Postgraduate Institute of Medical Education and Research (PGIMER), Nehru Hospital, Room No 18, 4th Level, F Block, Chandigarh, India., Vasudevan Nampoothiri R; Transplantation and Cellular Therapy Program, The Ottawa Hospital, University of Ottawa, Ottawa, ON Canada., Lad D; Department of Clinical Hematology and Medical Oncology, Postgraduate Institute of Medical Education and Research (PGIMER), Nehru Hospital, Room No 18, 4th Level, F Block, Chandigarh, India., Jandial A; Department of Clinical Hematology and Medical Oncology, Postgraduate Institute of Medical Education and Research (PGIMER), Nehru Hospital, Room No 18, 4th Level, F Block, Chandigarh, India., Sachdeva MUS; Department of Clinical Hematology and Medical Oncology, Postgraduate Institute of Medical Education and Research (PGIMER), Nehru Hospital, Room No 18, 4th Level, F Block, Chandigarh, India., Bose P; Department of Clinical Hematology and Medical Oncology, Postgraduate Institute of Medical Education and Research (PGIMER), Nehru Hospital, Room No 18, 4th Level, F Block, Chandigarh, India., Varma N; Department of Clinical Hematology and Medical Oncology, Postgraduate Institute of Medical Education and Research (PGIMER), Nehru Hospital, Room No 18, 4th Level, F Block, Chandigarh, India., Khadwal A; Department of Clinical Hematology and Medical Oncology, Postgraduate Institute of Medical Education and Research (PGIMER), Nehru Hospital, Room No 18, 4th Level, F Block, Chandigarh, India., Prakash G; Department of Clinical Hematology and Medical Oncology, Postgraduate Institute of Medical Education and Research (PGIMER), Nehru Hospital, Room No 18, 4th Level, F Block, Chandigarh, India., Malhotra P; Department of Clinical Hematology and Medical Oncology, Postgraduate Institute of Medical Education and Research (PGIMER), Nehru Hospital, Room No 18, 4th Level, F Block, Chandigarh, India.
Publikováno v:
Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion [Indian J Hematol Blood Transfus] 2024 Oct; Vol. 40 (4), pp. 580-587. Date of Electronic Publication: 2024 Aug 20.
Autor:
Chalchal H; Transplant and Cellular Therapy Program, Division of Hematology, The Ottawa Hospital, University of Ottawa, Ontario, Ottawa, Canada., Dhir V; Transplant and Cellular Therapy Program, Division of Hematology, The Ottawa Hospital, University of Ottawa, Ontario, Ottawa, Canada., Masurekar A; Transplant and Cellular Therapy Program, Division of Hematology, The Ottawa Hospital, University of Ottawa, Ontario, Ottawa, Canada., Atkins H; Transplant and Cellular Therapy Program, Division of Hematology, The Ottawa Hospital, University of Ottawa, Ontario, Ottawa, Canada., Bredeson C; Transplant and Cellular Therapy Program, Division of Hematology, The Ottawa Hospital, University of Ottawa, Ontario, Ottawa, Canada., Kennah M; Transplant and Cellular Therapy Program, Division of Hematology, The Ottawa Hospital, University of Ottawa, Ontario, Ottawa, Canada., Kekre N; Transplant and Cellular Therapy Program, Division of Hematology, The Ottawa Hospital, University of Ottawa, Ontario, Ottawa, Canada., Allan D; Transplant and Cellular Therapy Program, Division of Hematology, The Ottawa Hospital, University of Ottawa, Ontario, Ottawa, Canada., Vasudevan Nampoothiri R; Transplant and Cellular Therapy Program, Division of Hematology, The Ottawa Hospital, University of Ottawa, Ontario, Ottawa, Canada.
Publikováno v:
European journal of haematology [Eur J Haematol] 2024 Oct; Vol. 113 (4), pp. 543-549. Date of Electronic Publication: 2024 Jul 09.
Autor:
Maier SA; Cell Therapy Transplant Canada, Winnipeg, MB R3P 2R8, Canada., Ahmad I; Hôpital Maisonneuve-Rosemont, Montreal, QC H1T 2M4, Canada.; Faculté de Médecine, Université de Montréal, Montreal, QC H3T 1J4, Canada., Berg T; Faculty of Health Sciences, McMaster University, Hamilton, ON L8S 4L8, Canada.; Hamilton Health Sciences, Hamilton, ON L8N 3Z5, Canada., Berrigan S; Alberta Precision Laboratories, Calgary, AB T2N 4Z6, Canada., Elsawy M; Queen Elizabeth II Health Sciences Centre, Halifax, NS B3H 3A7, Canada.; Faculty of Medicine, Dalhousie University, Halifax, NS B3H 2Y9, Canada., Garcia-Horton A; Faculty of Health Sciences, McMaster University, Hamilton, ON L8S 4L8, Canada.; Hamilton Health Sciences, Hamilton, ON L8N 3Z5, Canada., Lam W; Princess Margaret Cancer Centre, Toronto, ON M5G 2C1, Canada., Lapworth A; Hamilton Health Sciences, Hamilton, ON L8N 3Z5, Canada., Melo Garcia L; Faculty of Medicine, CHU de Québec-Université Laval, Québec City, QC G1V 0A6, Canada., Shah RM; Alberta Children's Hospital, Calgary, AB T3B 6A8, Canada., Vasudevan Nampoothiri R; The Ottawa Hospital, Ottawa, ON K1H 8L6, Canada., Delisle JS; Hôpital Maisonneuve-Rosemont, Montreal, QC H1T 2M4, Canada.; Faculté de Médecine, Université de Montréal, Montreal, QC H3T 1J4, Canada.
Publikováno v:
Current oncology (Toronto, Ont.) [Curr Oncol] 2024 May 22; Vol. 31 (6), pp. 2918-2951. Date of Electronic Publication: 2024 May 22.
Autor:
Vasudevan Nampoothiri R; The Ottawa Hospital Transplantation and Cellular Therapy Program, University of Ottawa, Ottawa, Ontario, Canada, rvasudevan@toh.ca., Avery L; Department of Biostatistics, University Health Network, University of Toronto, Toronto, Ontario, Canada., Pasic I; Hans Messner Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada.; Department of Medicine, University of Toronto, Toronto, Ontario, Canada., Prassas I; Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada., Diamandis E; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.; Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada.; Department of Clinical Biochemistry, University Health Network, Toronto, Ontario, Canada., Michelis FV; Hans Messner Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada.; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
Publikováno v:
Acta haematologica [Acta Haematol] 2024; Vol. 147 (5), pp. 511-524. Date of Electronic Publication: 2024 Feb 08.
Autor:
Vasudevan Nampoothiri R; The Ottawa Hospital Bone Marrow Transplant Programme, University of Ottawa, Ottawa, Ontario, Canada., Tang K; Leukemia Program, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada., Schuh A; Leukemia Program, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada., Lam W; Hans Messner Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada., Maze D; Leukemia Program, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada., Michelis FV; Hans Messner Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada., Chan S; Leukemia Program, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada., Gupta V; Leukemia Program, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada., Kim D; Hans Messner Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada., Kumar R; Hans Messner Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada., Lipton JH; Hans Messner Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada., Mattsson J; Hans Messner Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada., Minden M; Leukemia Program, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada., Schimmer A; Leukemia Program, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada., Sibai H; Leukemia Program, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada., Viswabandya A; Hans Messner Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada., Yee K; Leukemia Program, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada., Murphy T; Leukemia Program, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada., Law AD; Hans Messner Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada.
Publikováno v:
European journal of haematology [Eur J Haematol] 2023 Jun; Vol. 110 (6), pp. 618-625. Date of Electronic Publication: 2023 Feb 16.
Autor:
Vasudevan Nampoothiri R; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Princess Margaret Cancer Center, University of Toronto, Toronto, Ontario, Canada., Pasic I; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Princess Margaret Cancer Center, University of Toronto, Toronto, Ontario, Canada., Law AD; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Princess Margaret Cancer Center, University of Toronto, Toronto, Ontario, Canada., Lam W; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Princess Margaret Cancer Center, University of Toronto, Toronto, Ontario, Canada., Chen C; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Princess Margaret Cancer Center, University of Toronto, Toronto, Ontario, Canada., Michelis FV; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Princess Margaret Cancer Center, University of Toronto, Toronto, Ontario, Canada., Kim DDH; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Princess Margaret Cancer Center, University of Toronto, Toronto, Ontario, Canada., Gerbitz A; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Princess Margaret Cancer Center, University of Toronto, Toronto, Ontario, Canada., Lipton JH; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Princess Margaret Cancer Center, University of Toronto, Toronto, Ontario, Canada., Kumar R; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Princess Margaret Cancer Center, University of Toronto, Toronto, Ontario, Canada., Mattsson J; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Princess Margaret Cancer Center, University of Toronto, Toronto, Ontario, Canada., Viswabandya A; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Princess Margaret Cancer Center, University of Toronto, Toronto, Ontario, Canada.
Publikováno v:
European journal of haematology [Eur J Haematol] 2022 May; Vol. 108 (5), pp. 430-436. Date of Electronic Publication: 2022 Feb 07.
Autor:
Maier SA; Cell Therapy Transplant Canada, Winnipeg, MB R3P 2R8, Canada., Berg T; Faculty of Health Sciences, McMaster University, Hamilton, ON L8S 4L8, Canada.; Hamilton Health Sciences, Hamilton, ON L8N 3Z5, Canada., Berrigan S; Alberta Precision Laboratories, Calgary, AB T2N 4Z6, Canada., Bramson J; Faculty of Health Sciences, McMaster University, Hamilton, ON L8S 4L8, Canada., Bredeson C; Ottawa Hospital Research Institute, Ottawa, ON K1H 8L6, Canada., Cantin G; Centre Hospitalier Universitaire de Québec-Hôpital de l'Enfant-Jésus, Quebec City, QC G1J 1Z4, Canada., Daly A; Alberta Bone Marrow Transplant Program, Calgary, AB T2N 4N2, Canada., Davies GA; Faculty of Health Sciences, McMaster University, Hamilton, ON L8S 4L8, Canada.; Hamilton Health Sciences, Hamilton, ON L8N 3Z5, Canada., Elsawy M; Queen Elizabeth II Health Sciences Centre, Dalhousie University, Halifax, NS B3H 2Y9, Canada., Garcia-Horton A; Faculty of Health Sciences, McMaster University, Hamilton, ON L8S 4L8, Canada.; Hamilton Health Sciences, Hamilton, ON L8N 3Z5, Canada., Lam W; Princess Margaret Cancer Centre, Toronto, ON M5G 2C1, Canada., Lapworth A; Hamilton Health Sciences, Hamilton, ON L8N 3Z5, Canada., Lepic K; Faculty of Health Sciences, McMaster University, Hamilton, ON L8S 4L8, Canada.; Hamilton Health Sciences, Hamilton, ON L8N 3Z5, Canada., Melo Garcia L; MD Anderson Cancer Center, Houston, TX 77030, USA., Schultz KR; British Columbia Children's Hospital Research Institute, Vancouver, BC V5Z 4H4, Canada., Vasudevan Nampoothiri R; Princess Margaret Cancer Centre, Toronto, ON M5G 2C1, Canada., White D; Queen Elizabeth II Health Sciences Centre, Dalhousie University, Halifax, NS B3H 2Y9, Canada., Delisle JS; Hôpital Maisonneuve-Rosemont, Université de Montréal, Montreal, QC H1T 2M4, Canada.
Publikováno v:
Current oncology (Toronto, Ont.) [Curr Oncol] 2022 Dec 19; Vol. 29 (12), pp. 9970-10017. Date of Electronic Publication: 2022 Dec 19.
Autor:
Vasudevan Nampoothiri R; Hans Messner Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada., Yeung J; Department of Thoracic Surgery, University Health Network, University of Toronto, Toronto, Ontario, Canada., Pierre A; Department of Thoracic Surgery, University Health Network, University of Toronto, Toronto, Ontario, Canada., Wong R; Department of Radiation Oncology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada., Darling G; Department of Thoracic Surgery, University Health Network, University of Toronto, Toronto, Ontario, Canada., Kim J; Department of Radiation Oncology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada., Siu LL; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada., Chen E; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada., Bouttell E; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada., Knox J; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada., Kim DDH; Hans Messner Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada., Lipton JH; Hans Messner Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada.
Publikováno v:
Journal of gastrointestinal oncology [J Gastrointest Oncol] 2022 Dec; Vol. 13 (6), pp. 2705-2712.
Autor:
Vasudevan Nampoothiri R; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, 610 University Avenue, Toronto, ON M5G 2M9 Canada., Viswabandya A; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, 610 University Avenue, Toronto, ON M5G 2M9 Canada.
Publikováno v:
Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion [Indian J Hematol Blood Transfus] 2021 Oct; Vol. 37 (4), pp. 521-527. Date of Electronic Publication: 2020 Aug 12.
Autor:
Vasudevan Nampoothiri R; Hans Messner Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Center, University of Toronto, Toronto, Ontario, Canada., Chen S; Hans Messner Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Center, University of Toronto, Toronto, Ontario, Canada., Pasic I; Hans Messner Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Center, University of Toronto, Toronto, Ontario, Canada., Al-Shaibani Z; Hans Messner Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Center, University of Toronto, Toronto, Ontario, Canada., Lam W; Hans Messner Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Center, University of Toronto, Toronto, Ontario, Canada., Michelis FV; Hans Messner Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Center, University of Toronto, Toronto, Ontario, Canada., Kim DDH; Hans Messner Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Center, University of Toronto, Toronto, Ontario, Canada., Viswabandya A; Hans Messner Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Center, University of Toronto, Toronto, Ontario, Canada., Gerbitz A; Hans Messner Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Center, University of Toronto, Toronto, Ontario, Canada., Lipton JH; Hans Messner Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Center, University of Toronto, Toronto, Ontario, Canada., Kumar R; Hans Messner Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Center, University of Toronto, Toronto, Ontario, Canada., Mattsson J; Hans Messner Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Center, University of Toronto, Toronto, Ontario, Canada., Law AD; Hans Messner Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Center, University of Toronto, Toronto, Ontario, Canada. Electronic address: arjun.law@uhn.ca.
Publikováno v:
Hematology/oncology and stem cell therapy [Hematol Oncol Stem Cell Ther] 2021 Jun; Vol. 14 (2), pp. 134-140. Date of Electronic Publication: 2020 Oct 08.